Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery.

@article{Bonarelli2015DabigatranEA,
  title={Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery.},
  author={Stefano Bonarelli and Maria Renata Bacchin and I Frugiuele and M A Feoli and Fabiana Facchini and V Altimari},
  journal={European review for medical and pharmacological sciences},
  year={2015},
  volume={19 5},
  pages={897-903}
}
OBJECTIVE Patients undergoing total hip replacement (THR) are at high risk of venous thromboembolism (VTE) and according to guidelines they should receive pharmacological prophylaxis. We would like to compare the efficacy, adherence and safety of dabigatran and low molecular weight heparins (LMWH) for the prevention of VTE in patients who underwent THR. PATIENTS AND METHODS This study enrolled patients undergoing THR treated with dabigatran (110 mg loading dose then 220 mg/day for 34 days) or… CONTINUE READING
3 Citations
13 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Similar Papers

Loading similar papers…